These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19622585)

  • 1. HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.
    Sun M; Behrens C; Feng L; Ozburn N; Tang X; Yin G; Komaki R; Varella-Garcia M; Hong WK; Aldape KD; Wistuba II
    Clin Cancer Res; 2009 Aug; 15(15):4829-37. PubMed ID: 19622585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER family receptor and ligand status in thymic carcinoma.
    Weissferdt A; Lin H; Woods D; Tang X; Fujimoto J; Wistuba II; Moran CA
    Lung Cancer; 2012 Sep; 77(3):515-21. PubMed ID: 22726920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
    Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
    Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.
    Scharpenseel H; Hanssen A; Loges S; Mohme M; Bernreuther C; Peine S; Lamszus K; Goy Y; Petersen C; Westphal M; Glatzel M; Riethdorf S; Pantel K; Wikman H
    Sci Rep; 2019 May; 9(1):7406. PubMed ID: 31092882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma.
    Sholl LM; John Iafrate A; Chou YP; Wu MT; Goan YG; Su L; Huang YT; Christiani DC; Chirieac LR
    Mod Pathol; 2007 Oct; 20(10):1028-35. PubMed ID: 17673923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
    Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent overexpression of ErbB--receptor family members in brain metastases of non-small cell lung cancer patients.
    Berghoff AS; Magerle M; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckman K; Marosi C; Wöhrer A; Hackl M; Zöchbauer-Müller S; Preusser M; Birner P
    APMIS; 2013 Dec; 121(12):1144-52. PubMed ID: 23756255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.
    Younes M; Wu Z; Dupouy S; Lupo AM; Mourra N; Takahashi T; Fléjou JF; Trédaniel J; Régnard JF; Damotte D; Alifano M; Forgez P
    Oncotarget; 2014 Sep; 5(18):8252-69. PubMed ID: 25249545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification.
    Tanizaki J; Okamoto I; Sakai K; Nakagawa K
    Br J Cancer; 2011 Sep; 105(6):807-13. PubMed ID: 21847121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of EGFR and KRAS status between primary non-small cell lung cancer and corresponding metastases: a systematic review and meta-analysis].
    Han C; Zou H; Ma J; Zhou Y; Zhao J
    Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):882-91. PubMed ID: 20840818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer.
    Zhang Y; Yang H; Qiu Y; Deng Q; Liu J; Zhao M; He P; Mo M; Zou X; He J
    Med Oncol; 2014 Mar; 31(3):803. PubMed ID: 24452282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies.
    Udagawa H; Nilsson MB; Robichaux JP; He J; Poteete A; Jiang H; Heeke S; Elamin YY; Shibata Y; Matsumoto S; Yoh K; Okazaki S; Masuko T; Odintsov I; Somwar R; Ladanyi M; Goto K; Heymach JV
    J Thorac Oncol; 2024 Jan; 19(1):106-118. PubMed ID: 37678511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer.
    Yun S; Kwak Y; Nam SK; Seo AN; Oh HK; Kim DW; Kang SB; Lee HS
    Cancer Res Treat; 2018 Oct; 50(4):1351-1361. PubMed ID: 29361822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis.
    Breindel JL; Haskins JW; Cowell EP; Zhao M; Nguyen DX; Stern DF
    Cancer Res; 2013 Aug; 73(16):5053-65. PubMed ID: 23794705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites.
    Bozzetti C; Tiseo M; Lagrasta C; Nizzoli R; Guazzi A; Leonardi F; Gasparro D; Spiritelli E; Rusca M; Carbognani P; Majori M; Franciosi V; Rindi G; Ardizzoni A
    J Thorac Oncol; 2008 Jan; 3(1):18-22. PubMed ID: 18166836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G Protein-Coupled Receptor PAC1 Regulates Transactivation of the Receptor Tyrosine Kinase HER3.
    Moody TW; Lee L; Jensen RT
    J Mol Neurosci; 2021 Aug; 71(8):1589-1597. PubMed ID: 32964398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas.
    Tang X; Varella-Garcia M; Xavier AC; Massarelli E; Ozburn N; Moran C; Wistuba II
    Cancer Prev Res (Phila); 2008 Aug; 1(3):192-200. PubMed ID: 19138956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer.
    Jeon YK; Sung SW; Chung JH; Park WS; Seo JW; Kim CW; Chung DH
    Lung Cancer; 2006 Dec; 54(3):387-98. PubMed ID: 17011067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.
    Byeon SJ; Lee HS; Kim MA; Lee BL; Kim WH
    Pathobiology; 2017; 84(4):210-217. PubMed ID: 28399526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
    Iida M; Brand TM; Starr MM; Huppert EJ; Luthar N; Bahrar H; Coan JP; Pearson HE; Salgia R; Wheeler DL
    Mol Cancer; 2014 Oct; 13():242. PubMed ID: 25344208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.